Pharma deal potentially great news, but there are worries over funding
1 December 2025
Daniel Elkeles responds to the UK-US pharmaceuticals deal.
Finance
Prevention
Responding to the announcement of the UK-US pharmaceuticals deal, the chief executive of NHS Providers, Daniel Elkeles, said:
"This deal is potentially very good news for patients, for the NHS and for UK life sciences.
"It is great that NHS patients will have increased access to groundbreaking new treatments.
"The announcement also builds on the longstanding close partnership between the NHS and the pharmaceutical industry, making this the best place in the world to carry out clinical trials.
"However it is not yet clear how it will be paid for.
"There is absolutely no slack in current published NHS spending plans for this major commitment and that is a real worry for trust leaders."
Related articles
InsightsA brighter future is possible in 2026
5 Jan 2026In this blog Daniel Elkeles looks ahead to some of the challenges for the NHS in 2026.
Delivery and performance
Finance
Quality
Workforce
- News
New model of care for people living with frailty could be a 'gamechanger'
Daniel Elkeles responds to a National Audit Office report on healthcare for people living with frailty.
Community
Integration
Prevention
- News
Funding is a barrier for successful mental health services
2 Dec 2025Daniel Elkeles responds to a report by the Health and Social Care Select Committee on community mental health services.
Community
Finance
Mental health